A draft update to the US Food and Drug Administration’s guidance document on premarket regulation of medical device cybersecurity clarifies the agency’s expectations around establishing cyber threat protection in submissions for so-called “cyber devices.”
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?